Significance of High hsCRP Levels
High-sensitivity C-reactive protein (hsCRP) is an independent marker of cardiovascular risk that indicates underlying inflammation and can predict future cardiovascular events, with levels >3 mg/L indicating high cardiovascular risk requiring more aggressive preventive measures. 1
Cardiovascular Risk Assessment
High hsCRP levels have significant implications for cardiovascular health:
Risk stratification categories 1:
- Low risk: <1.0 mg/L
- Average risk: 1.0-3.0 mg/L
- High risk: >3.0 mg/L
- Mild inflammation: 10-40 mg/L
- Acute inflammation/bacterial infection: 40-200 mg/L
- Severe acute illness: >500 mg/L
Clinical application in cardiovascular disease:
- hsCRP can help reclassify patients at intermediate risk (10-20% 10-year CHD risk) to high-risk category (>20% 10-year CHD risk) 2
- Elevated hsCRP predicts incident myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death 3
- hsCRP provides additional prognostic value beyond traditional risk factors like cholesterol levels, blood pressure, and Framingham risk score 3
Clinical Decision Algorithm
For patients without known cardiovascular disease:
For patients with established cardiovascular disease:
For markedly elevated hsCRP (>10 mg/L):
Non-Cardiovascular Significance
High hsCRP levels can also indicate:
Chronic inflammatory disorders 1:
- Rheumatoid arthritis
- Inflammatory bowel disease (especially Crohn's disease)
- Vasculitis
Infections 1:
- Bacterial infections typically cause more pronounced elevations (40-200 mg/L)
- Note that hsCRP has moderate specificity (40-67%) as a marker of bacterial infection
Factors Influencing hsCRP Levels
Factors that increase hsCRP 1:
- Elevated blood pressure
- High BMI
- Smoking
- Diabetes
- Low HDL/high triglycerides
- Hormone replacement therapy
- Chronic infections/inflammation
Factors that decrease hsCRP 1:
- Moderate alcohol consumption
- Physical activity/exercise
- Weight loss
- Medications (statins, fibrates, niacin)
Important Clinical Considerations
Two measurements of hsCRP (optimally 2 weeks apart) in metabolically stable patients should be averaged for clinical decision-making 1
Serial testing of hsCRP should not be used to monitor the effects of treatment for cardiovascular disease (Class III recommendation) 2
The combination of elevated hsCRP and hypertension significantly increases cardiovascular risk in patients with stable coronary artery disease 4
hsCRP measurement enhances information provided by lipid screening or global risk assessment 5
Caveats and Pitfalls
hsCRP is a non-specific marker of inflammation and should be interpreted in clinical context alongside other findings 1
Application of management guidelines for Acute Coronary Syndromes should not depend on hsCRP levels (Class III recommendation) 2
Significant inter-individual variability in CRP response exists due to genetic factors 1
While hsCRP predicts cardiovascular risk, the benefits of therapy based solely on hsCRP levels remain uncertain 2